| INTRODUCTION
Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome is a rare, X linked recessive disease of autoimmunity due to the lack of development of T regulatory (Treg) cells that are critical to the development of self-tolerance (Powell, Buist, & Stenzel, 1982; Verbsky and Chatila, 2013) (OMIM #304790). The phenotype includes diarrhea, enteropathy, eczema, and insulin-dependent diabetes mellitus, typically presenting in the first year of life (Barzaghi, Passerini, & Bacchetta, 2012) . The skin findings in IPEX syndrome include atopic dermatitis and psoriasiform lesions. Frequently, elevated levels of IgE can be associated with skin desquamation over the limbs (Halabi-Tawil et al., 2009 ). The limited number of reports of IPEX syndrome indicates that the disease is rare, and there is no estimated rate of incidence. Infants with IPEX syndrome lack CD4 + /CD25 + Treg cells in the blood and tissues and female carriers display a skewed X inactivation in CD4 + /CD25 + cells (Di while simultaneously downregulating the autoimmune cytokines IL-2, IFN-γ, and IL-4 (Bettelli, Dastrange, & Oukka, 2005; Fontenot, Gavin, & Rudensky, 2003; Hori, Nomura, & Sakaguchi, 2003; Khattri, Cox, Yasayko, & Ramsdell, 2003; Ramsdell and Ziegler, 2014; Wu et al., 2006) . Patients with pathogenic alterations in FOXP3 fail to generate Tregs, and due to the Tregs' central role in self-tolerance, this results in severe autoimmunity (Bettelli et al., 2005) .
IPEX syndrome is a rare disorder reported in over 150 individuals, with 50 pathogenic alterations in FOXP3 and no clear genotypephenotype correlation (d 'Hennezel, Bin Dhuban, Torgerson, Piccirillo, & Piccirillo, 2012) . Although heterogeneous, the majority of IPEX syndrome patients have onset of disease in infancy [Baris et al., 2014; Barzaghi et al., 2012; d'Hennezel et al., 2012] . Recently, five families were described with fetuses with IPEX syndrome; prenatal clinical findings included hydrops, intrauterine growth restriction (IUGR), and prematurity (Rae et al., 2015; Reichert, McKay, & Moldenhauer, 2015; Vasiljevic et al., 2015; Xavier-da-Silva et al., 2015) . Here, we present two novel inherited frameshift mutations in FOXP3 that introduce premature stop codons and cause fetal forms of IPEX syndrome. Both affected male fetuses presented with in utero desquamation of the skin and prominent echogenic loops of bowel detected by ultrasound.
These cases broaden the disease spectrum of IPEX syndrome in the prenatal setting, with important implications for early detection.
The mother was a 31-year-old gravida 3, para 1, abortus one female referred to Maternal-Fetal Medicine (MFM) at 19 and 6/7 weeks gestation for evaluation of echogenic bowel found on a standard obstetrical ultrasound at her primary obstetrician's office. A detailed anatomy scan at the MFM office revealed no findings of echogenic bowel, no other abnormalities, and normal biometric parameters. A follow up targeted scan at 23 weeks gestation, revealed mildly prominent bowel loops and skin projections on the face, shoulders, arms, and neck, as demonstrated on 3D rendering ( Figure 1A ).
Premature rupture of membranes and vaginal bleeding occurred at 25 weeks gestation. A targeted ultrasound revealed low amniotic fluid with echogenic debris, scalp edema, and echogenic debris in the stomach. At 27 weeks gestation, ongoing sloughing and thickening of the skin was noted ( Figure 1B ). Additionally, mild ascites and pleural effusions were identified by targeted ultrasound. The prenatal genetics team at the Greenwood Genetic Center was consulted, and the diagnoses of epidermolysis bullosa and ichthyosis were considered based on the ultrasound findings of echogenic amniotic fluid and fetal skin desquamation. Soon after, the fetus was noted to be hydropic on ultrasound, and the patient delivered via repeat low transverse cesarean section at 27 weeks 2 days. Apgar scores were 2 at 1 min and 1 at 5 min. At birth, the skin was partially sloughed with underlying erythema, but the remaining epidermis appeared to be tight and shiny. Resuscitation was attempted but intubation was not successful. The infant died after 1 hr.
On postmortem examination, the 27-week-male infant weighed 904 g (60th centile), crown-rump length was 22.9 cm (25th centile), and crown-heel length was 33.4 cm (40th centile). There was extensive desquamation of skin over the entire body leaving erythematous and pale areas of residual skin ( Figure 1C ). Exfoliative erythroderma involved most of the skin surface. No intact bullae were present. The palpebral fissures appeared small, and hypertelorism was noted. Clinodactyly of the fifth finger was present. The upper gastrointestinal system and trachea contained debris, but were patent. No meconium was present. The heart, liver, spleen, and kidneys were enlarged (1.5, 2.5, 6.3, and 2.1 times expected weights, respectively), likely secondary to edema. External morphologic and radiographic measurements were consistent with the gestational age.
Histological examination of the skin showed epidermal necrosis, milia and dermal infiltration of lymphocytes, histiocytes, eosinophils, and multinucleated giant cells ( Figure 1D ).
The family history included a healthy maternal half-brother, and a pregnancy loss with a different maternal partner. The maternal grandmother had a history of four pregnancy losses, two occurred in the second trimester ( Figure 1E ). The two second trimester losses were both males, but no anomalies were noted, and no specific etiology for the recurrent losses was identified.
| Patient 2
The mother was a 20-year-old gravida 1, para 0 female who presented late to prenatal care at 26 weeks gestation. Detailed anatomic obstetrical ultrasound was notable for echogenic amniotic fluid with particulate appearance and sediment layering, as well as echogenic debris in the stomach ( The infant was born at 35 weeks gestation. His birth weight (1.74 kg) was at the 11th percentile for his gestational age. Apgar scores were 5 at 1 min, 6 at 5 min, and 7 at 10 min. He required positive pressure ventilation and supplemental oxygen for approximately 1 min for apnea. During neonatal resuscitation, 20-30 ml of yellowish-greenish thick liquid poured out from his anus, and 10-15 ml of thick yellow secretions were withdrawn from his stomach.
Debris that resembled skin was found in the stool and in his mouth.
He was otherwise stable and was admitted to the neonatal intensive care unit. His skin was pale, grey, and dry with mild desquamation and ecchymoses on the lower limbs. Dermatology determined that his hyperpigmentation was consistent with dermal melanosis and recommended moisturizers for mild skin desquamation. Additional family testing revealed that the maternal grandmother, who had four pregnancy losses of which at least two were male, is a carrier of the FOXP3 mutation, which is likely de novo in her ( Figure 1E ). The maternally related unaffected males did not carry the FOXP3 variant. Therefore, the inherited frameshift alteration in FOXP3 is believed to be causative of the prenatal presentation of IPEX in this patient. The family received genetic counseling for IPEX syndrome.
Karyotype performed from amniocytes and cord blood was normal male (46,XY). SNP microarray performed on cord blood showed an abnormal male result with duplication of at least 597 kb of DNA from 16p11.2, which was maternally inherited. This duplication is unrelated to IPEX and confers a predisposition for developmental delay/autism (Rosenfeld et al., 2010 Given the 16p11.2 duplication found on microarray, his development was closely monitored. He had gross developmental delay and at age 2 years was unable to walk independently, and had no words. It is likely that his prolonged hospitalization also contributed to his delays.
The family did not report a history of developmental delay, autism, or recurrent miscarriage. The family received genetic counseling for IPEX syndrome and the 16p11.2 duplication, including recurrence risks and phenotypic presentations.
| DISCUSSION
FOXP3, in partnership with NFAT and NF-κB, controls the expression of over 800 genes (Katoh et al., 2011) and is necessary and sufficient for the development of Tregs (Hori et al., 2003) . The exact repertoire and timing of the genes expressed under the developmental control of FOXP3 are still being dissected. However, recent reports have shown that FOXP3 upregulates cell surface markers CD25, CTLA-4, CD103, and GITR while simultaneously downregulating the cytokines IL-2, IFN-γ, and IL-4 thereby preventing autoimmunity (Bettelli et al., 2005; Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003; Wu et al., 2006) . Currently, treatment of IPEX includes bone hematopoetic stem cell transplantation or immune suppression with cyclosporin A or FK506.
FOXP3 is composed of four domains: repression, zinc finger, leucine zipper, and FKH domains. The FKH domain is required for
proper nuclear localization (Lopes et al., 2006) and interfaces with the NFAT and NF-κB transcription factors (Bettelli et al., 2005; Lopes et al., 2006) . Truncation of the FKH domain causes cytoplasmic localization of FOXP3 and reduced transcriptional activity (Lopes et al., 2006) . The majority of disease-causing alterations occur in the FKH domain, highlighting the importance of intracellular localization (Lopes et al., 2006; Verbsky and Chatila, 2013) . Phenotypic severity of IPEX syndrome has been hypothesized to correlate with the extent of residual protein function (Barzaghi et al., 2012) , and typically point mutations or small inframe deletions that do not alter functional protein domains are associated with less severe phenotypes (d 'Hennezel et al., 2012) .
However, functional studies of disease-causing alterations are required to fully define a genotype-phenotype correlation. The first patient described herein has an inherited frameshift alteration introducing a premature stop codon in exon 8, and the second patient has a frameshift alteration resulting in a stop codon in The majority of previously reported pathogenic mutations have been missense, not causing frameshift or a truncated protein product. In reviewing the prior reports with prenatal presentations of IPEX (Table 1) , we note that the majority of these mutations disrupt the FKH domain (Vasiljevic et al., 2015; Xavier-da-Silva et al., 2015) or abolish its expression (Rae et al., 2015; Reichert et al., 2015) . In light of our findings and in line with these prior reports, disruption or absence of the FKH domain could explain the early onset of IPEX symptoms, given the importance of this domain for the function of (Table 1) .
Echogenic bowel is a relatively nonspecific finding, identified in up to 1.8% of routine second trimester ultrasound exams.
Differential diagnosis considered with fetal echogenic bowel is very broad, including intra-amniotic bleeding, fetal cystic fibrosis, fetal aneuploidy (e.g., trisomy 21, 13, 18), congenital infection 
